Determinants of adequate lymph node dissection following neoadjuvant chemotherapy in patients with urothelial muscle-invasive bladder cancer: results from the National Cancer Database

[1]  J. Gore,et al.  Quality Indicators for Bladder Cancer Services: A Collaborative Review. , 2020, European urology.

[2]  A. Lenis,et al.  Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival. , 2020, Urologic oncology.

[3]  A. Kibel,et al.  Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era , 2018, World Journal of Urology.

[4]  F. Montorsi,et al.  Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study , 2018, World Journal of Urology.

[5]  S. Lipsitz,et al.  Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy. , 2017, Urologic oncology.

[6]  Yair Lotan,et al.  Treatment of Non‐Metastatic Muscle‐Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline , 2017, The Journal of urology.

[7]  Sanjay G. Patel,et al.  Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. , 2015, European urology.

[8]  F. Montorsi,et al.  Stage‐specific impact of pelvic lymph node dissection on survival in patients with non‐metastatic bladder cancer treated with radical cystectomy , 2012, BJU international.

[9]  F. Montorsi,et al.  Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study. , 2011, The Journal of urology.

[10]  R. Naspro,et al.  Pelvic lymphadenectomy during radical cystectomy: a review of the literature. , 2010, Surgical oncology.

[11]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[12]  B. Bochner,et al.  Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard. , 2007, Seminars in oncology.

[13]  Sam S. Chang,et al.  Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. , 2004, The Journal of urology.

[14]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.